COMMUNIQUÉS West-GlobeNewswire
-
Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term
19/11/2026 -
Communiqué de presse : VaxRabeo, le vaccin contre la rage de nouvelle génération de Sanofi, approuvé dans l’UE pour tous les âges
19/11/2026 -
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
19/11/2026 -
Interim Results for the Third Quarter of 2026 - BioPorto reports continued NGAL growth and advances the U.S. Adult Validation Study
19/11/2026 -
Scancell Provides Corporate and Clinical Update
19/11/2026 -
DISCO Pharmaceuticals Announces Strategic Collaboration with AbbVie to Advance Next-Generation AND-Gated Bispecific Therapeutics for Solid Tumors
19/11/2026 -
AVA6207 Overcomes Topoisomerase I Inhibitor Resistance In Vitro and In Vivo with Robust and Tumor-Selective Release of Dual Exatecan and ATR Inhibitor Payloads
19/11/2026 -
SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering
19/11/2026 -
Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management Initiative
19/11/2026 -
Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
19/11/2026 -
Livsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing
19/11/2026 -
Rosedil Introduces Rosedil Capsules, a Biotin, Zinc and Horsetail Dietary Supplement for Hair Wellness Routines
19/11/2026 -
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
19/11/2026 -
Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
19/11/2026 -
Tevogen Highlights Significant Liability Reduction and Continued Insider Control
18/11/2026 -
Grant of Restricted Stock Units and Warrants to Employees in Genmab
18/11/2026 -
Lakefront Creates New Subscription Right Plan
18/11/2026 -
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
18/11/2026 -
PROCEPT BioRobotics® to Participate in the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026
18/11/2026
Pages